# Green Cross Holdings

Green Cross Holdings is a Corporate Investor based in Yongin-si, South Korea.

## Overview

- **Organization type:** Corporate Investor
- **Headquarters:** Yongin-si, South Korea
- **Region:** Asia
- **Address:** 107 Ihyeon-ro 30beon-gil Giheung-gu, Yongin-si, Gyeonggi-do, 16924, South Korea
- **Founded:** 1967
- **Assets under management:** 873 (Altss estimate)
- **Website:** www.gccorp.com
- **LinkedIn:** https://www.linkedin.com/company/gc-holdings

## Regulatory record

- **Reports private funds:** No

## About

Green Cross Holdings was founded in 1967 as the parent of the Green Cross Group. Heo Il-sup serves as chairman. The structure centers on control of pharmaceutical manufacturing and related healthcare businesses rather than external fund commitments. The firm deploys capital through direct ownership of subsidiaries and selective venture positions. Asset classes include listed equities in biotechnology, industrial manufacturing sites, and minority stakes in early-stage companies. Confirmed holdings include GC Biopharma, GC Cell, GC Wellbeing and limited partner positions in Humanscape. Geographic focus remains South Korea with one co-founded US biotechnology entity, Artiva Biotherapeutics. Assets total 873 million USD. The group operates six specialized production and research facilities in Yongin, Hwasun, Ochang, and Eumseong. September 2024: Spoke at DeSci Seoul 2024 on R&D Leveraging Blockchain and Decentralized Science. Four foundations support health and education causes, including the MOGAM Institute for Biomedical Research established in 1984. Ownership passes through family members with Heo Yong-jun as CEO of the holding company and Heo Eun-chul leading the main biopharma subsidiary. This integrated operating-company model distinguishes the entity from pure financial investors.

## Sectors

- Healthcare
- Pharmaceuticals
- Biotechnology

## People

- Heo Il-sup — Chairman
- Heo Yong-jun — CEO
- Heo Eun-chul — CEO of GC Biopharma

## Questions

### Who runs investment decisions at Green Cross Holdings?

Heo Il-sup serves as chairman. Heo Yong-jun acts as CEO of the holding company. Decisions center on direct ownership of operating subsidiaries.

### Does Green Cross Holdings participate in fund commitments or only direct deals?

Activity focuses on direct ownership and operating subsidiaries. Limited partner positions appear in three South Korean startups.

### What investment stages does Green Cross Holdings typically target?

Holdings span listed equities, established operating businesses, and early-stage startups. Ticket sizes range from 10 to 100 million USD.

## Related profiles

- [PA Laborers' District Council](https://altss.com/profile/pa-laborers-district-council)
- [Pirelli UK](https://altss.com/profile/pirelli-uk)

---

Last updated: 2026-06-03T20:00:00.000Z

Canonical page: https://altss.com/profile/green-cross-holdings

Maintained by Altss — https://altss.com — methodology: https://altss.com/methodology